Intrinsic Value

Taysha Gene Therapies, Inc. (TSHA)


+0.03 (+3.82%)

Enterprise Value -
Net Debt -149.10
Equity Value -
Shares Outstanding 17.67
Equity Value Per Share -

Because investors are more interested in the value of the company’s shares alone, we’ll deduct net debt from this value to arrive at a fair value of the company’s equity. Fair Value = Enterprise Value – Debt